SaliMark OSCC salivary test for oral cancer

PeriRx LLC, a developer of breakthrough, non-invasive, oral diagnostic technology, recently made its national debut.

“We’re using a variety of ways to engage with members of the dental community and tell them about SaliMark OSCC, the most clinically advanced salivary test for oral cancer,” said Stephen M. Swanick, CEO and founder of PeriRx LLC.

Development of this simple-to-use, painless and accurate test was based on the strong scientific foundation of NIH-funded research, with initial discovery and pre-validation work conducted by Dr. David Wong of the University of California at Los Angeles.

What’s more, more than a decade of National Institute of Dental and Craniofacial Research and National Institute of Health-supported research make SaliMark OSCC the world’s most scientifically validated molecular DNA biomarker test for oral squamous cell carcinoma.